Alto Neuroscience Announces Positive Data from Phase 1 Study Evaluating Brain Effects of Novel Drug Combinations
Click here to view original web page at Alto Neuroscience Announces Positive Data from Phase 1 Study Evaluating Brain Effects of Novel Drug Combinations – Results demonstrate robust therapeutic potential of proprietary drug combinations, validating the Company’s method of identifying and targeting core pathways to improve brain function – – EEG, behavioral, and patient-reported outcomes … Continue reading “Alto Neuroscience Announces Positive Data from Phase 1 Study Evaluating Brain Effects of Novel Drug Combinations”